Ranaz Corporation to raise funds through private placement

NewsGuard 100/100 Score

Ranaz Corporation ("Ranaz") (TSXV: RNZ), a company specialized in the manufacturing and marketing of protein and dietary supplements, announces that it intends to raise $675,000 through a non-brokered private placement of units. Each unit, priced at $0.065 will consist of one common share of Ranaz and one share purchase warrant (exercise price: $0.10), which will expire five years from their issue date. A maximum of 20,769,228 common shares of Ranaz may be issued under this private placement (assuming the exercise of all warrants).

An insider of Ranaz, Fiducie Vanquish, will subscribe for more than 25% of the private placement.

Closing of this private placement will be subject to the approval of the TSX Venture Exchange.

Source:

RANAZ CORPORATION

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Balancing diets: study reveals plant protein's impact on nutrient levels in Americans